Document Detail

Gemfibrozil in dyslipidaemia.
MedLine Citation:
PMID:  2199426     Owner:  NLM     Status:  MEDLINE    
A new lipid regulating agent, Gemfibrozil was evaluated in different types of dyslipidaemias. Out of a total of 34 patients, all completed 12 weeks' treatment and 26 completed 24 weeks' of treatment. A significant reduction in total cholesterol, LDL-c triglyceride and apo-B and an increase in HDL cholesterol and its apoprotein--apo-A were observed. The patients belonged to hyperlipidaemias--types IIa, IIb, and IV. Patients' compliance was good and side effects were minimal.
S C Kundu; S Roxy; S K Batabyal
Related Documents :
7825526 - Effect of apolipoprotein e polymorphism on the serum lipid response to a hypolipidemic ...
2139916 - Effect of ketoconazole on plasma sex hormones, lipids, lipoproteins, and apolipoprotein...
9225216 - Intraindividual variations in lipoprotein (a) levels and factors related to these changes.
20181806 - Effects of atorvastatin and n-3 fatty acid supplementation on vldl apolipoprotein c-iii...
7608916 - Evidence for kairomonal influence on selection of host-ambushing sites by adult ixodes ...
18676716 - Odorant production and persistence of escherichia coli in manure slurries from cattle f...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of the Association of Physicians of India     Volume:  38     ISSN:  0004-5772     ISO Abbreviation:  J Assoc Physicians India     Publication Date:  1990 Feb 
Date Detail:
Created Date:  1990-09-11     Completed Date:  1990-09-11     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7505585     Medline TA:  J Assoc Physicians India     Country:  INDIA    
Other Details:
Languages:  eng     Pagination:  156-9     Citation Subset:  IM    
Dept. of Biochemistry, B.R. Singh Hosp., Calcutta.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cholesterol / blood
Clinical Trials as Topic
Drug Administration Schedule
Drug Evaluation
Gemfibrozil / administration & dosage,  therapeutic use*
Hyperlipidemias / blood,  drug therapy*
Middle Aged
Triglycerides / blood
Reg. No./Substance:
0/Triglycerides; 25812-30-0/Gemfibrozil; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prophylactic use of mexiletine in the elderly with acute myocardial infarction.
Next Document:  Herniography in adults: review and personal studies.